Skip to main content
. 2018 Mar 23;63(5):1123–1138. doi: 10.1007/s10620-018-5000-0

Fig. 5.

Fig. 5

Schematics of tumoroid technology platform for anti-CSC drug discovery and tumoroid-based clinical drug response assay